Lin Yu-ting cleared to return to women’s boxing competition

Olympic champion Lin Yu-ting has been cleared to compete in female boxing after World Boxing confirmed she met the governing body’s new qualification requirements. The 30-year-old Taiwanese boxer, who won the women’s featherweight title for Chinese Taipei at the 2024 Paris Olympics, had become embroiled in a prominent qualification controversy alongside Algeria’s Imane Khelif. Both boxers were formerly banned from the 2023 World Championships by the International Boxing Association, which pointed to failure to meet women’s competition standards. World Boxing, which took over governance of the sport at Olympic level after the IOC’s suspension of the IBA, implemented mandatory sex testing in August 2025. Lin’s clearance comes after a completed appeal process and medical review by World Boxing’s impartial specialists.

The eligibility row that shook Olympic boxing

Lin Yu-ting’s clearance signals a major milestone in one of Olympic sport’s most contentious eligibility disputes. The row broke out when the International Boxing Association excluded both Lin and Khelif from the 2023 World Championships, claiming they had not satisfied the requirements for participation in women’s competitions. In spite of this rejection, Lin subsequently win the Olympic gold medal in Paris a few months later, performing under IOC oversight after the governing body removed the IBA of its standing due to significant integrity and governance issues. The episode revealed fundamental rifts within the boxing establishment and posed difficult questions about eligibility testing and equity in women’s sport.

The disagreement heightened the scrutiny concerning eligibility policies in women’s boxing at the top tiers of sport. Lin’s non-participation from numerous competitions following the governing body’s implementation of required sex verification in August 2025 highlighted the ambiguity concerning her standing. The review mechanism, whilst thorough and ultimately vindicated the athlete, underscored the psychological and career impact of prolonged eligibility questions. World Boxing’s decision to implement objective medical evaluation systems represented an bid to develop more explicit, better-defined guidelines for the sport going forward.

• IBA disqualified Lin and Khelif from 2023 World Championships
• IOC suspended IBA over governance failures and integrity concerns
• Lin won Olympic gold despite eligibility row in Paris
• World Boxing implemented compulsory sex testing in August 2025

World Boxing’s updated testing protocol detailed

World Boxing’s mandatory sex testing policy, established in August 2025, constitutes a fundamental shift in how the sport approaches eligibility verification. The updated system focuses on a specific genetic test designed to determine biological sex through scientific analysis, superseding the former approach that had generated widespread controversy. This method aims to provide objective criteria that can be measured that World Boxing contends will safeguard both sporting integrity and athlete safety. The policy covers all competitors in women’s divisions and features a formal appeals procedure, enabling competitors to dispute initial findings with supporting medical evidence. This framework is intended to create consistency and transparency across international boxing competitions.

The implementation of mandatory testing has demonstrated importance for athletes like Lin Yu-ting, who experienced prolonged ambiguity whilst the updated protocol was introduced. World Boxing’s choice to incorporate an separate clinical assessment element indicates understanding of the intricacy of eligibility determinations. The appeal process permits boxers to provide detailed medical records for evaluation by World Boxing’s Medical Committee, ensuring that individual circumstances get adequate attention. This equitable method endeavours to integrate evidence-based standards with administrative justice, acknowledging that biological sex lacks simplicity. The organisation emphasises that the policy’s core purpose is upholding competitive integrity whilst defending athlete welfare and dignity throughout the validation process.

How the SRY genetic test operates

The SRY gene test functions by detecting the presence of a specific gene that World Boxing identifies as an indicator of male biological sex. The test examines genetic material to determine whether the Y chromosome is detected, which generally defines male development. According to World Boxing, this genetic marker offers an scientifically measurable indicator that can inform eligibility decisions. The test represents a move towards scientific methodology in determining sex determination, departing from previous approaches that were based on different criteria. Results are evaluated by impartial clinical experts who assess the findings in the wider clinical setting.

Athletes who test positive for the SRY gene are not automatically disqualified; instead, they proceed through an appeal process allowing them to submit additional medical evidence. World Boxing’s Medical Committee examines all submitted documentation thoroughly before making final eligibility decisions. This appeals mechanism recognises that genetic testing by itself may not provide the full biological picture, particularly for athletes with conditions impacting sex development. The assessment process considers medical history, hormone levels, and other pertinent clinical factors in conjunction with genetic results. This multi-faceted approach seeks to ensure that determinations are scientifically valid and individually appropriate rather than determined solely on single test results.

• Detects Y chromosome presence confirming male sex determination
• Positive results initiate independent medical review appeals procedure
• Medical Committee evaluates genetic and clinical evidence comprehensively

The appeal mechanism and medical evidence

Following an preliminary assessment in 2025, the Chinese Taipei Boxing Association initiated a official challenge on Lin’s behalf, providing detailed medical evidence to World Boxing for impartial examination. The appeal mechanism is a critical safeguard within World Boxing’s eligibility framework, enabling competitors to challenge original screening outcomes by providing supporting clinical evidence. This process acknowledges that sex classification is multifaceted and that genetic indicators alone do not provide the full picture of an individual’s medical history and biological makeup. The CTBA’s decision to pursue the challenge demonstrated faith in Lin’s case and dedication to clearing her name through proper channels.

The provision of medical documents represented a pivotal moment in the resolution of Lin’s competitive standing. World Boxing’s medical specialists conducted a comprehensive assessment of all evidence presented, taking into account not only DNA testing outcomes but also wider medical considerations including hormonal measurements, clinical background, and other relevant biological factors. This thorough methodology guaranteed that the decision was grounded in complete medical assessment rather than single test findings. The stringent examination procedure demonstrated World Boxing’s commitment to determining outcomes that are both scientifically sound and personally suitable, whilst preserving the standards of women’s sport.

What the medical board established

The World Boxing Medical Committee determined that Lin had been female since birth and met all standards for competing in the female category, with no performance advantage. This determination came after careful evaluation of the medical documentation and represented a conclusive outcome to the eligibility matter that had dominated her career since the 2023 World Championships. The committee’s ruling upheld Lin’s right to compete at the highest levels of women’s boxing, clearing the path for her return to international competition.

What comes next for Lin and women’s boxing

Lin’s clearance constitutes a significant turning point not only for her career but for female boxing more broadly. The 30-year-old can now return to competition in World Boxing-sanctioned events after sitting out many events since the compulsory sex testing requirement was established in August 2025. Her return represents a chance to reclaim her status as a two-time world champion and build on her Olympic gold medal from Paris. The resolution also provides resolution for the CTBA, which has firmly stood behind Lin throughout the disputed eligibility proceedings and celebrated the validation of her status.

The case carries wider significance for how international sports bodies handle eligibility policies and competitor wellbeing. World Boxing’s decision to implement a comprehensive appeal process with independent medical review sets a precedent for balancing competitive integrity with personal justice. As Lin gets ready to compete to the ring, her return to competition will be closely watched by the professional boxing world and beyond, potentially influencing how other sporting bodies create and improve their own qualification criteria. The way ahead emphasises the importance of comprehensive, open procedures that respect both the science of sex determination and the human dignity of athletes.

• Lin can now participate in all World Boxing-sanctioned global tournaments unrestricted.
• The appeal process reflects World Boxing’s dedication to impartial, evidence-driven eligibility decisions.
• Her comeback bolsters faith in women’s boxing’s oversight under this new regulatory structure.